Hjem › Tykktarmskreft › North Carolina › Durham
Kliniske studier for Tykktarmskreft i Durham, NC
12 studier for Tykktarmskreft søker deltakere på steder i og rundt Durham (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of PHN-012 in Patients With Advanced Solid Tumors
RekruttererFase 1
- PHN-012-001 Site, Durham
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RekruttererFase 3
- Duke Cancer Center - Investigational Chemotherapy Service, Durham
- Duke Cancer Center, Durham
- Duke University Hospital - Vascular Interventional Radiology, Durham
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
RekruttererFase 3
- The University of North Carolina At Chapel Hill, Chapel Hill · 10 mi unna
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RekruttererObservasjonsstudie
- UNC- Chapel Hill, Chapel Hill · 10 mi unna
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
RekruttererFase 2/3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi unna
Shield Post-Approval Study Protocol
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi unna
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi unna
- University of North Carolina at Chapel Hill, Hillsborough · 13 mi unna
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
RekruttererFase 1
- Xencor Investigative Site, Durham
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
RekruttererFase 1
- Research Site, Durham
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RekruttererFase 1
- Duke Cancer Center, Durham
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
RekruttererFase 3
- GSK Investigational Site, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi unna
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
RekruttererFase 2
- University of North Carolina, Chapel Hill · 10 mi unna
Tykktarmskreft-studier i andre byer
- Boston, MA22 studier
- New York City, NY22 studier
- Houston, TX20 studier
- Los Angeles, CA16 studier
- Nashville, TN16 studier
- St. Louis, MO15 studier
- Arlington, VA15 studier
- Chicago, IL14 studier
- San Antonio, TX14 studier
- Baldwin Park, CA14 studier
- Baltimore, MD13 studier
- Tampa, FL13 studier
Andre studier i Durham
- Brystkreft64 studier
- Kreft (alle typer)58 studier
- Ikke-småcellet lungekreft39 studier
- Multipelt myelom37 studier
- Akut myelogen leukemi33 studier
- Metastatisk kreft33 studier
- Prostatakreft32 studier
- Lungekreft32 studier
- Kolorektal kreft28 studier
- Eggstokkreft27 studier
- Kronisk lymfatisk leukemi27 studier
- Hjertesvikt26 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.